Exclusive

Publication

Byline

UTI Fixed Term Income Fund - Series XXXV - I (1260 DAYS), into UTI Corporate Bond Fund and UTI Nifty SDL Plus AAA PSU Bond Apr 2026 75:25 Index Fund i

India, March 21 -- UTI Mutual Fund has approved the merger of UTI Fixed Term Income Fund - Series XXXV - I (1260 DAYS), into UTI Corporate Bond Fund and UTI Nifty SDL Plus AAA PSU Bond Apr 2026 75:25 ... Read More


WhiteOak Capital MF announces change in benchmark under its scheme

India, March 21 -- WhiteOak Capital Mutual Fund has announced a change in the benchmark of the WhiteOak Capital Multi Asset Allocation Fund, with effect from April 23, 2026. Change in name of Benchmar... Read More


HDFC MF announces Income Distribution cum Capital Withdrawal (IDCW) under its schemes.

India, March 21 -- HDFC Mutual Fund has announced 24 March 2026 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) on the face value of Rs 10 per unit under the re... Read More


Vikram Solar appoints Sameer Nagpal as CEO

India, March 21 -- Sameer Nagpal holds Post Graduate Diploma in Business Management from IIM Calcutta, Mechanical Engineering from Delhi College of Engineering (now DTU) and is also affiliated with mu... Read More


Tata Motors PV announces marginal price hike on ICE portfolio from 1 April'26

India, March 21 -- The weighted average price increase will be 0.5 % of ICE portfolio and the extent will vary across models and variants. Tata Motors Passenger Vehicles (formerly Tata Motors), part o... Read More


India hits landmark of one billion tonne coal production

India, March 21 -- India has successfully achieved the landmark of 1 billion tonne (BT) coal production on 20.03.2026 for the second year in a row, according to Ministry of Coal. This significant mile... Read More


Glenmark Pharma launches GLIPIQ (semaglutide) in India for Type 2 Diabetes at lower cost

India, March 21 -- The company said the decision to start advanced injectable therapy is often delayed in many patients due to cost and complexity. With GLIPIQ, Glenmark aims to improve affordability ... Read More


Zydus launches semaglutide injection under three brands in India

India, March 21 -- The company said the Drug Controller General of India (DCGI) had earlier approved the manufacturing and marketing of the Semaglutide injection for the treatment of both Type 2 Diabe... Read More


Dr Reddy's launches Obeda (semaglutide) in India for Type 2 Diabetes

India, March 21 -- The company said it is the first Indian pharmaceutical firm to receive approval from the Drugs Controller General of India (DCGI) for generic semaglutide, enabling a day-one launch ... Read More


Sun Pharma launches semaglutide injection under two brands in India

India, March 21 -- The company said Noveltreat is indicated for chronic weight management in adults, to be used alongside a reduced-calorie diet and increased physical activity. It is available in fiv... Read More